These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8413750)

  • 41. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
    Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
    Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.
    Diserens K; Ruegg D; Kleiser R; Hyde S; Perret N; Vuadens P; Fornari E; Vingerhoets F; Seitz RJ
    Neurorehabil Neural Repair; 2010 Oct; 24(8):753-62. PubMed ID: 20663964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate].
    Keren O; Shinberg F; Catz A; Giladi N
    Harefuah; 2000 Feb; 138(3):204-8, 270. PubMed ID: 10883093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM
    Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of spasticity with botulinum toxin and muscle afferent block].
    Kaji R; Mezaki T; Kubori T; Murase N; Kimura J
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1334-5. PubMed ID: 9128398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel approach to the application of botulinum toxin to the flexor digitorum superficialis muscle in acquired brain injury.
    Munin MC; Navalgund BK; Levitt DA; Breisinger TP; Zafonte RD
    Brain Inj; 2004 Apr; 18(4):403-7. PubMed ID: 14742153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.
    Borg-Stein J; Pine ZM; Miller JR; Brin MF
    Am J Phys Med Rehabil; 1993 Dec; 72(6):364-8. PubMed ID: 8260129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial.
    Koman LA; Mooney JF; Smith BP; Goodman A; Mulvaney T
    J Pediatr Orthop; 1994; 14(3):299-303. PubMed ID: 8006158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin injection techniques for the management of adult spasticity.
    Walker HW; Lee MY; Bahroo LB; Hedera P; Charles D
    PM R; 2015 Apr; 7(4):417-27. PubMed ID: 25305369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of spasticity with botulinum toxin.
    Borodic GE; Ferrante R; Wiegner AW; Young RR
    Ann Neurol; 1992 Jan; 31(1):113. PubMed ID: 1543342
    [No Abstract]   [Full Text] [Related]  

  • 54. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.
    Hyman N; Barnes M; Bhakta B; Cozens A; Bakheit M; Kreczy-Kleedorfer B; Poewe W; Wissel J; Bain P; Glickman S; Sayer A; Richardson A; Dott C
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):707-12. PubMed ID: 10811692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Traditional pharmacological treatments for spasticity. Part I: Local treatments.
    Gracies JM; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of cerebral palsy with botulinum-A toxin: preliminary investigation.
    Koman LA; Mooney JF; Smith B; Goodman A; Mulvaney T
    J Pediatr Orthop; 1993; 13(4):489-95. PubMed ID: 8370782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of treatment with botulinum toxin on spasticity.
    Das TK; Park DM
    Postgrad Med J; 1989 Apr; 65(762):208-10. PubMed ID: 2594595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intramuscular nerve distribution pattern of the adductor longus and gracilis muscles demonstrated with Sihler staining: guidance for botulinum toxin injection.
    Won SY; Rha DW; Kim HS; Jung SH; Park ES; Hu KS; Kim HJ
    Muscle Nerve; 2012 Jul; 46(1):80-5. PubMed ID: 22644785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Botulinum toxin. Use in the treatment of spasticity in children].
    Rasmussen LN
    Ugeskr Laeger; 2000 Nov; 162(48):6557-61. PubMed ID: 11187227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intramuscular neurolysis for spasticity in children.
    Easton JK; Ozel T; Halpern D
    Arch Phys Med Rehabil; 1979 Apr; 60(4):155-8. PubMed ID: 475567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.